Home›Companies›Biotech & Pharma›Abcuro

Abcuro, Inc.

Develops immunotherapies for people with autoimmune diseases and cancer.

Updated Nov 9, 2026·Latest SEC filing Aug 13, 2026·Suggest an edit

About Abcuro

Abcuro is a private company based in Newton, Massachusetts. It has reported $265,274,794 raised in six offerings on Form D since December 2016. Its chief executive is John Martin.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Aug 7, 2026Aug 13, 2026$39,383,108of $176.5M target23$1.7MEquityRule 506(b)Form D ↗
Feb 7, 2025Feb 19, 2025$79,999,955of $199.9M target21$3.8MEquityRule 506(b)Form D ↗
Aug 11, 2023Aug 25, 2023$120,141,750of $199.5M target21$5.7MEquityRule 506(b)Form D ↗
Jun 23, 2020Jul 6, 2020amended Jan 22, 2021$15,499,981of $42.0M target15$1.0MEquityRule 506(b)Form D/A ↗1 earlier filing
Nov 9, 2018Nov 21, 2018$8,000,000fully sold3$2.6MEquityRule 506(b)Form D ↗
Nov 30, 2016Dec 13, 2016$2,250,000fully sold4$562KEquityRule 506(b)Form D ↗
Total, six offerings$265,274,794

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Abcuro's Form D filed Aug 13, 2026.

JM
John Martin
Chief Executive Officer and director
Michael Dybbs
Michael Dybbs
Partner, Samsara BioCapital and director
RH
Ron Hunt
Director
Ming Fang
Ming Fang
Managing Director, Redmile Group
Also a director at Clear Labs and GRO Biosciences.
Mark Pruzanski
Mark Pruzanski
Chairman of the Board
Also a director at eGenesis.

Earlier filings also listed Rajeev Shah (director, last listed Feb 2025), Michele Park (director, last listed Feb 2025), Jason Hafler (director, last listed Feb 2025), Tomer Kariv (director, last listed Aug 2023), Richard Motschwiller (executive officer, last listed Aug 2023), Julius Knowles (director, last listed Aug 2023), Donald McCarthy (director, last listed Aug 2023) and Darlene Deptula-Hicks (director, last listed Aug 2023).

Sources

  1. SECAbcuro, Inc. Form D, filed Jul 6, 2020
  2. SECAbcuro, Inc. filing history
  3. CompanyPrivacy policy
  4. CompanyContact
  5. CompanyAbout Abcuro
  6. CompanySeries D financing announcement